Two die, one in critical condition after a gas leak at Pharma City, Parawada
At the time of incident three employees became unconscious after inhaling the gas.
The deceased were identified as Parimi Chandrasekhar, safety manager from Telangana, and Saragadam Kumar, safety officer from Munagapaka. Meanwhile, another worker Baidu Baisal, a helper from Odisha, is undergoing treatment in the hospital.
The bodies of the deceased were shifted to King George Hospital mortuary.
Meanwhile, trade union leaders alleged that the management failed in following safety standards and demanded a compensation of Rs.1 crore for the families of the deceased.
(eom)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
24 minutes ago
- Indian Express
323 PGI staff houses lie vacant, causing Rs 5.5 crore annual loss
As many as 323 houses meant for faculty and non-faculty staff of the Post Graduate Institute of Medical Education and Research (PGI) in Sectors 12 and 24 have been lying vacant for years, causing an annual financial loss of around Rs 5.5 crore, information obtained under the Right to Information (RTI) Act has revealed. According to the RTI reply, the losses are on account of forgone licence fees and the payment of 20% house rent allowance (HRA) to staff who could have been accommodated in these quarters. Over the last five to six years, the non-allotment of vacant houses has cost PGI more than Rs 20 crore. Applicant Ashwani Kumar Munjal, an honorary member of the PGI Employees' Union (Non-Faculty), said many of these houses have remained unoccupied from 2017 to 2025, even as several employees wait for official accommodation. 'Staff have to rent homes in far-off areas at high rates. This puts a heavy financial burden on them and delays their arrival for duty due to traffic congestion, ultimately affecting patient services,' he said. The RTI reply also shows that many of these houses have been locked up for years, rendering them uninhabitable. While PGI suffers rental losses running into several lakh rupees annually, it continues to incur expenses on the upkeep and security of these properties. Residential accommodation at PGI is primarily meant for faculty, resident doctors, nurses, and other staff. However, due to various reasons — from long-pending repairs to unsuitable location or size — 323 houses remain unallotted. A recent 'fitness report' of the vacant quarters flagged severe issues, including wall cracks, leaking roofs, faulty sewage and plumbing systems, unsafe electrical wiring, and dilapidated doors and windows. These problems have delayed allotment and driven up annual maintenance costs. Meanwhile, demand for on-campus housing remains high, with new doctors and employees often forced to rent costly accommodation outside. Staff representatives say timely repair and maintenance could prevent further financial losses and ease the housing crunch. Proposals under consideration include earmarking a separate repair budget and launching large-scale renovations to bring the locked quarters back into use.
India Today
an hour ago
- India Today
Indian-origin US doctor fined $2M for false surgery billing fraud
A 63-year-old Indian-origin pain medicine doctor based in Houston, Texas, has agreed to pay more than $2 million (approximately Rs 17.4 crore) to settle allegations of healthcare fraud, according to the US Ajay Aggarwal agreed to pay $2,053,515 to resolve claims that he submitted false billing to Medicare and to the Department of Labor's Workers' Compensation Programs between November 2021 and March 2023, for surgical procedures that were never actually is an anesthesiologist and pain medicine doctor who also practices in Texas' Bellaire city, Lake Jackson city and Van Vleck (in Matagorda County). He runs his medical practice, called The Pain Relief & Wellness Center, through his own business and a company named PRWCSWTX LLC, according to the statement issued on Monday (August 11) by the US Attorney's Office, Southern District of Texas. Aggarwal billed federally funded healthcare programmes for the surgical implantation of neurostimulator electrodes, according to the statement. These are invasive procedures usually requiring use of an operating room. As a result, Medicare and other federally funded healthcare programmes pay thousands of dollars per procedure, the statement neither Aggarwal nor his staff performed these surgical procedures, according to the allegations, the statement further investigators said Aggarwal instead used electro-acupuncture devices on his patients, which involved inserting thin wires into the ear and taping a small neurostimulator behind the ear – none of which required surgery or treatments were done at Aggarwal's clinic, not a hospital or surgical centre, and no incision was made on a patient, according to the VOWS TO RECOVER LOSSES FROM FRAUDULENT MEDICARE BILLINGUS attorney Nicholas J Ganjei slammed the "fraudulent billing" by the doctor and vowed to recover the losses."A doctor who uses simple medical devices on his patients, yet bills Medicare for a sophisticated spinal surgery, is bilking the American taxpayer, plain and simple," said Ganjei."The Southern District of Texas will ensure that losses to federally funded healthcare programs from fraudulent billing, like what happened here, are recouped and that wrongdoers are held accountable," the attorney month, a doctor of Indian-origin admitted guilt to federal charges related to illegally prescribing strong opioids, resulting in the overdose deaths of two part of his plea, Sanjay Mehta admitted to writing unjustified prescriptions for oxycodone, methadone, and Roxicodone (a branded form of oxycodone hydrochloride) to three different patients in Virginia."Two of the three customers died of opioid intoxication within days of receiving their unlawful prescriptions," US Attorney's Office said in a quantum of Mehta's punishment will be announced on October 31.- Ends
Time of India
2 hours ago
- Time of India
Scientists find a gut microbe that works as a natural alternative to Ozempic
Image credits: Getty Images Science has made life way easier than it could ever have been without it. From antidotes and vaccines to alternatives, when science is at work, everything is possible. In a surprising turn of events, scientists may have just found a way to naturally regulate blood sugar levels and sugar cravings without the use of injectables such as Ozempic. A gut microbe and its metabolites proved to be the key in unlocking the natural process in humans and mice due to the compound it produced during digestion, as per a study published in Nature Microbiology. Researchers led by a team at Jiangnan University in China showed how they can "orchestrate the secretion of glucagon-like peptide-1" in diabetic mice by increasing the abundance of this particular gut microbe. Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and helps it regulate blood sugar levels and feelings of fullness. Its release is stimulated by certain foods and gut microbes, and its mechanism of action is mimicked by drugs like semaglutide, the ingredient behind Ozempic. Ozempic comes in as a saviour for people with type 2 diabetes who have an impaired GLP-1 function, thus causing issues with blood sugar control. These drugs mimic the natural processes in the body, and while they are highly effective, researchers do want to probe how to get the body to produce more GLP-1 on its own. "A growing body of research has revealed that our cravings for dietary components originate from signals sent from the gut, a key organ in transmitting dietary preferences," explained the authors in the paper. "However, which genes, gut flora, and metabolites in the gut microenvironment are involved in the regulation of sugar preference is currently unclear." Which gut microbe is it? Image credits: Getty Images The research suggests gut microbes like Bacteroides vulgatus and their metabolites may help shape a person's sweet tooth. In the experiments, if mice could not produce a gut protein called Ffar4, the gut colonies of reduced. This, in turn, reduced the release of a hormone called FGF21, which it connected to sugar cravings. The GLP-1 options when used in mice, are known to stimulate FGF21. Meanwhile, in humans, some studies suggest that those with variants of the FGF21 hormone are about 205 times more likely to be top-ranking consumers of sweet foods. In a blood analysis of 60 participants with type 2diabetes and 24 healthy controls, researchers in China found that Ffar4 mutations that reduce FGF21 production are linked to an increased preference for sugar, "which may be an important contributor to the development of diabetes." However, when mice were treated with a metabolite of it boosted GLP-1 secretion and also triggered the secretion of FGF21. This meant more blood sugar control and less sugar cravings in mice.
